Javier Torres Corredor

Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Yada Kanjanapan, Sheau Wen Lok, Peter Gibbs, Richard De Boer, Belinda Yeo, Sally Greenberg, Frances Barnett, Louise Knott, Gary Richardson, Rachel Wong, Michelle Nottage, Ian M Collins, Javier Torres, Janine Lombard, Julie Johns, Michael Harold, Laeeq Malik

Journal article  |  2020  |  Breast Cancer Research and Treatment

PURPOSE: Trastuzumab, pertuzumab, and docetaxel are the standard first-line therapy for HER2-positive (HER2+) metastatic breast ca..

Treatment outcomes for metastatic castrate-resistant prostate cancer (mCRPC) patients (pts) following docetaxel (D) for hormone sensitive disease

Andrew Lachlan Schmidt, Angelyn Anton, Shirley S Wong, Arun Azad, Edmond Michael Kwan, Lavinia Anne Spain, Javier Torres, Arunbalaji Muthusamy, Phillip Parente, Francis Parnis, Jeffrey C Goh, Anthony M Joshua, David William Pook, Peter Gibbs, Ben Tran, Andrew James Weickhardt

Conference Proceedings  |  2020  |  JOURNAL OF CLINICAL ONCOLOGY

Anticancer therapy within the last 30 days of life: results of an audit and re-audit cycle from an Australian regional cancer centre

Mike Nguyen, Sean Ng Ying Kin, Evonne Shum, Alysson Wann, Babak Tamjid, Arvind Sahu, Javier Torres

Journal article  |  2020  |  BMC Palliative Care

A Victorian clinician-based survey on current practices for breast cancer staging in pregnancy

Harriet Herbison, Abigail Miller, Christopher D Hart, Theresa Hayes, Darryl Shnier, Josephine Stewart, Lee Na Teo, Jacqui Thomson, Javier Torres, Sally Greenberg, Bianca Devitt

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Real-World Use of First-Generation Anti-androgens (FGAs): Their Influence on Patient Outcomes and Subsequent Therapies in Metastatic Castration-Resistant Prostate Cancer (mCPRC)

Richard Kelly, Angelyn Anton, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun Azad, Edmond Kwan, Lavinia Spain, Arun Muthusamy, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Anthony Joshua, David Pook, Peter Gibbs, Ben Tran

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Potential length of stay reduction with outpatient management of low risk febrile neutropenia in a regional cancer centre.

Mike Nguyen, Tate Jacobson, Babak Tamjid, Javier Torres, Arvind Sahu, Alysson Wann

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Anticancer therapy within the last 30 days of life: Results of an audit and re-audit cycle from a regional cancer center.

Nguyen Mike, Alysson Wann, Babak Tamjid, Arvind Sahu, Javier Torres

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literature.

Jennifer A Soon, Angelyn Anton, Javier Torres, Ruth Lawrence, Phillip Parente, Joseph McKendrick, Ian D Davis, Carmel Pezaro

Journal article  |  2019  |  Supportive Care in Cancer

PURPOSE: Testicular seminomas occur in young men and are highly curable. Toxicities following treatment for men with extensive sta..

Febrile neutropenia in a regional setting; epidemiology and microbiology findings

Catherine Mannering, Tate Jacobson, Arvind Sahu, Alysson Wann, Babak Tamjid, Javier Torres

Conference Proceedings  |  2018  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Previous Bevacizumab and Efficacy of Later Anti-Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International Registry

Matthew Burge, Christine Semira, Belinda Lee, Margaret Lee, Suzanne Kosmider, Rachel Wong, Jeremy Shapiro, Brigette Ma, Andrew P Dean, Allan S Zimet, Simone A Steel, Sheau Wen Lok, Javier Torres, Melissa Eastgate, Hui-li Wong, Peter Gibbs

Journal article  |  2018  |  Clinical Colorectal Cancer